Roche's Expensive Avastin Denied UK Approval For Breast Cancer
 

The United Kingdom's regulatory board, has rejected Avastin (bevacizumab) for the treatment of patients suffering from metastatic breast cancer. There is simply not enough proof that the drug is truly beneficial in upping survival rates...

More...